Stifel Financial’s Instil Bio TIL Stock Holding History

Stifel Financial’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-825	Closed	-$7.06K	–	3413
2023 Q3	$7.06K	Hold	825	–	–	﹤0.01%	3266
2023 Q2	$9.09K	Hold	825	–	–	﹤0.01%	3305
2023 Q1	$10.9K	Hold	825	–	–	﹤0.01%	3310
2022 Q4	$10.4K	Buy	825 +250	+43%	+$12.4K	﹤0.01%	3270
2022 Q3	$56K	Hold	575	–	–	﹤0.01%	3176
2022 Q2	$53K	Hold	575	–	–	﹤0.01%	3225
2022 Q1	$124K	Hold	575	–	–	﹤0.01%	3227
2021 Q4	$197K	Hold	575	–	–	﹤0.01%	3155
2021 Q3	$206K	Buy	+575	New	+$215K	﹤0.01%	3122

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Stifel Financial's TIL Position: Q4 2023 in Review

Stifel Financial sold out of Instil Bio (TIL) in Q4 2023, closing a stake of 825 shares — an estimated $7.06K sold.

Stifel Financial first reported a position in TIL in Q3 2021 and held it in 9 quarters. The position peaked at $206K in Q3 2021. 30 funds tracked by Wall St. Rank hold TIL as of Q4 2023.

Stifel Financial reported no remaining Instil Bio position as of Q4 2023 after selling out during the quarter.
Stifel Financial sold 825 Instil Bio shares in Q4 2023, an estimated $7.06K.
Stifel Financial first reported a position in Instil Bio in Q3 2021 and held it in 9 quarters.
Stifel Financial's Instil Bio position peaked at $206K in Q3 2021.
30 funds tracked by Wall St. Rank held Instil Bio as of Q4 2023.

Based on Stifel Financial's 13F filing for Q4 2023, filed 12 Feb 2024.